ArticlePharmaceuticals (Basel, Switzerland)2025

Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management.

Kristina Zarif Attalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.